Ischemic heart disease Board decisions

The Board denied earlier effective dates for service connection and ratings, but granted a 10 percent rating for hypertension from May 25, 2021.

The appeal concerning the issues of entitlement to service connection for hypertension and coronary artery disease is dismissed due to the Veteran's death.

The Board remands the issues of service connection for skin cancer, ischemic heart disease (IHD), and a lung disability due to insufficient evidence.

The Board remands the claims for service connection for a heart disability and prostate cancer due to insufficient efforts in obtaining necessary documentation.

The Board remands the issue of entitlement to service connection for a heart condition, to include mitral valve insufficiency, as directed development has not been completed.

The Board granted service connection for coronary artery disease (CAD) and a right ankle disorder as secondary to service-connected pes planus, but remanded several other issues including entitlement to an initial compensable evaluation for various scars and TDIU.

The Board denied an earlier effective date for the 100 percent disability rating for PTSD prior to February 1, 2023, and remanded several service connection claims.

The Board granted service connection for diabetes mellitus, left lower extremity diabetic peripheral neuropathy, right lower extremity diabetic peripheral neuropathy, and erectile dysfunction. The CAD rating was increased to 60 percent effective February 23, 2021.

The appeal was dismissed due to the Veteran's death prior to the issuance of a final Board decision.

The Board denied service connection for diabetes mellitus, type II, hypertension, heart disease (congestive heart failure with arteriosclerotic heart disease, valvular heart disease, cardiomegaly and aortic aneurysm), and hyperlipidemia as the evidence did not support that these conditions were incurred in or aggravated by service.

The Board granted service connection for hypertension, multiple myeloma, prostate cancer, hypothyroidism, and a heart condition as secondary to service-connected hypertension due to herbicide exposure.

The appeal for an initial rating in excess of 30 percent for coronary artery disease was dismissed, and the effective date for service connection for both coronary artery disease and prostate cancer residuals could not be earlier than September 27, 2021.

The Board granted service connection for hypertension under the Presumption of Service Connection due to herbicide exposure, as provided by the PACT Act. The heart condition claim was remanded for further development.

The Board remands the claim for further development related to the Veteran's exposure to Agent Orange during service.

The Board denied earlier effective dates for service connection and denied increased ratings, except for a 70% rating for major depressive disorder (MDD) from November 21, 2012, and a total disability rating based on individual unemployability due to MDD from the same date. The Board also granted special monthly compensation at the housebound rate from June 10, 2014.

The Board remands the claim for service connection for heart disability to correct a duty to assist error related to obtaining relevant non-VA treatment records.

The Board denied an effective date prior to January 29, 2024, for the award of service connection for heart disabilities as secondary to hypertension.

The Board remands the claim for an earlier effective date for a TDIU rating to refer it to the Director of the Compensation Service for extraschedular consideration.

The Veteran withdrew his appeal for an increased rating for coronary artery disease, and the Board dismissed the claim.

The Board granted service connection for coronary artery disease but denied a rating in excess of 40 percent for lumbar spine degenerative disc/joint disease and a TDIU prior to April 16, 2016.